These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2402310)

  • 21. [Use of human recombinant erythropoietin in patients for chronic renal insufficiency].
    Wanic-Kossowska M
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):129-31. PubMed ID: 8090663
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythropoietin therapy in renal failure.
    Paganini EP; Miller T
    Adv Intern Med; 1993; 38():223-43. PubMed ID: 8438638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibodies against human recombinant erythropoietin: an unusual cause of erythropoietin resistance].
    Virón B; Kolta A; Kiladjian JJ; Mignon F; Mayeux P; Casadevall N
    Nephrologie; 2002; 23(1):19-22. PubMed ID: 11887573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Improvement of sexual function in hemodialyzed male patients with chronic renal failure treated with erythropoietin (rHuEPO)].
    Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
    Przegl Lek; 1995; 52(9):462-6. PubMed ID: 8834648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant erythropoietin: 10 years of clinical experience.
    Valderrábano F
    Nephrol Dial Transplant; 1997; 12 Suppl 1():2-9. PubMed ID: 9075222
    [No Abstract]   [Full Text] [Related]  

  • 28. Resistance to rHuEpo and kidney graft rejection.
    Page B; Zingraff J
    Nephrol Dial Transplant; 1994; 9(11):1696. PubMed ID: 7870369
    [No Abstract]   [Full Text] [Related]  

  • 29. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
    Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
    Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recombinant human erythropoietin].
    Frenken LA; Koene RA
    Ned Tijdschr Geneeskd; 1988 Mar; 132(10):432-4. PubMed ID: 3347279
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 33. Health-related quality of life in the era of erythropoietin.
    Weisbord SD; Kimmel PL
    Hemodial Int; 2008 Jan; 12(1):6-15. PubMed ID: 18271834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The exercise-during-hemodialysis program: report on a pilot study.
    Ridley J; Hoey K; Ballagh-Howes N
    CANNT J; 1999; 9(3):20-6. PubMed ID: 15712469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract]   [Full Text] [Related]  

  • 36. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
    Caillette A; Barreto S; Gimenez E; Labeeuw M; Zech P
    Clin Nephrol; 1993 Sep; 40(3):176-8. PubMed ID: 8403574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythropoietin and chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Zingraff J; Delons S; Kreis H; Varet B
    Nouv Rev Fr Hematol (1978); 1989; 31(2):97-8. PubMed ID: 2771635
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.